Search for: "Dmitry Karshtedt" Results 1 - 20 of 32
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
31 Oct 2022, 7:01 am by Jason Rantanen
Dmitry Karshtedt: Nonobviousness and Time   [read post]
10 Mar 2011, 11:09 am by Lisa Larrimore Ouellette
This is a guest post by Dmitry Karshtedt, a 3L at Stanford with a Ph.D. in chemistry. [read post]
3 Nov 2022, 4:38 pm by Unknown
   GW Law Biography Dmitry Karshtedt's primary research interest is in patent law. [read post]
16 Sep 2014, 3:24 pm by Lisa Larrimore Ouellette
I am delighted to welcome Stanford Law & Biosciences Fellow Dmitry Karshtedt as a new Written Description blogger. [read post]
22 Apr 2021, 10:05 am by Jason Rantanen
Dmitry Karshtedt is an Associate Professor of Law at GW Law whose work I’ve followed for years. [read post]
8 Nov 2022, 3:23 am by Brian Leiter
I'm sorry to report the untimely passing of Professor Karshtedt, a well-regarded patent law scholar, who was recently tenured at George Washington University. [read post]
1 Nov 2022, 5:52 am by Irina Manta
The post In Memoriam: Dmitry Karshtedt (1977-2022) appeared first on Reason.com. [read post]
4 Dec 2018, 2:51 pm by Howard Bashman
And at the “Patently-O” blog, Dmitry Karshtedt has a guest post titled “Of Brownies and Other Nutty Desserts: Supreme court considers whether the ‘on sale’ bar is limited to public sales. [read post]
19 Apr 2011, 7:49 pm by Lisa Larrimore Ouellette
Stanford 3L Dmitry Karshtedt, who has guest posted on this blog, has a new post on Stanford's Law and Biosciences Blog about biologics, which are complicated drugs like erythropoietin that are typically made using living cells, as distinct from easily replicated small-molecule drugs like aspirin.Karshtedt discusses his new paper, Limits on Hard-To-Reproduce Inventions: Process Elements and Biotechnology's Compliance with the Enablement Requirement, in which he argues that… [read post]
27 Nov 2017, 11:56 am
" And at the "Patently-O" blog, law professor Dmitry Karshtedt has a guest post titled "Oil States: Engaging with History, Private Property, and the Privy Council. [read post]
27 Nov 2017, 11:30 am by Dennis Crouch
 Dmitry Karshtedt This morning’s argument in Oil States v. [read post]
2 Jun 2021, 3:34 pm by Sabrina I. Pacifici
Janis, Mark David and Sichelman, Ted M. and Allison, John R. and Cotter, Thomas F. and Cotropia, Christopher Anthony and Karshtedt, Dmitry and Lefstin, Jeffrey A. and Rantanen, Jason and Taylor, David O. and Tu, Shine (Sean), Patent Law: An Open-Source Casebook (Entire Book) (May 6, 2021). [read post]
6 Nov 2022, 8:53 am by Jason Rantanen
 This has been a topic to watch at the Federal Circuit, and two major law professor articles, one written by Mark Lemley and Jake Sherkow and the other co-authored by Dmitry Karshtedt, Sean Seymore, and Mark Lemley, have pointed out the problems with the Federal Circuit’s approach to genus claims, especially in the context of inventions such as antibodies. [read post]
11 Jul 2021, 8:41 am by Juvan Bonni
 Dmitry Karshtedt: Nonobviousness: Before and After (Source: SSRN) New Job Postings on Patently-O: Knobbe Martens – Patent Scientist (Electrical Engineering) Knobbe Martens – Patent Scientist (Bilingual Japanese/English) Knobbe Martens – Patent Scientist (Biotechnology) Ballard Spahr LLP NPDS Design Services, LLC DBJG One World Technologies [read post]
18 Apr 2021, 5:21 pm by Juvan Bonni
 Dmitry Karshtedt: Nonobviousness: Before and After (Source: SSRN) Atty. [read post]
29 Apr 2021, 6:39 am by Dennis Crouch
by Dennis Crouch In their forthcoming article, Professors Dmitry Karshtedt, Mark A. [read post]
16 Jul 2011, 4:46 pm by Lisa Larrimore Ouellette
Most of these papers are not available on SSRN or elsewhere yet, but you can read Dmitry Karshtedt's Did Learned Hand Get It Wrong? [read post]
4 Aug 2014, 5:38 am by Lisa Larrimore Ouellette
"Dmitry Karshtedt (Law & Biosciences Fellow, Stanford): Courts have imposed "completeness requirement" based on hodgepodge of doctrines; should recognize in new statutory provision and create new "research patent" for claims that meet other standards but fail completeness.Shawn Miller (Lecturer & Fellow, Stanford; co-author: Mark Lemley): District court judges are less likely to be reversed by the Federal Circuit after they sit with that court by… [read post]
24 Apr 2023, 6:10 am by The Petrie-Flom Center Staff
Yet Dmitry Karshtedt held otherwise at the ASLME Health Law Professor’s Conference in Atlanta, GA in 2017. [read post]